Biogen (BIIB) Tops Q1 EPS by 30c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $254.46 +2.22%
Financial Fact:
Diluted earnings per share attributable to Biogen Idec Inc.: 4.71
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Diluted earnings per share attributable to Biogen Idec Inc.: 4.71
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q1 EPS of $5.34, $0.30 better than the analyst estimate of $5.04. Revenue for the quarter came in at $2.69 billion versus the consensus estimate of $2.65 billion.
GUIDANCE:
Biogen sees FY2021 EPS of $17.50-$19.00, versus the consensus of $18.41. Biogen sees FY2021 revenue of $10.45-10.75 billion, versus the consensus of $10.57 billion.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sezzle Inc. (SEZL) Reports Q3 EPS of $1.37 ; Offers Guidance
- Relay Therapeutics, Inc. (RLAY) Tops Q3 EPS by 3c
- Veeco Instruments (VECO) Misses Q3 EPS by 9c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
